Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on ...
Once-weekly insulin icodec-abae (Awiqli; Novo Nordisk) is now approved to improve glycemic control in children 10 years and ...
Relapse outcomes were largely null in major RCTs, including SOLAR and VIDAMS, despite numerically lower ARR in some analyses ...
Columbia’s Jai Radhakrishnan, MD, MS, explains how FSGS differs by phenotype and why new IgA nephropathy drugs reach so few ...
Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers. Across many disease ...
Long-acting injectable HIV pre-exposure prophylaxis (LAI PrEP) could significantly reduce HIV infections, but disparate ...
Chronic kidney disease (CKD) risk stratification that flagged high-risk patients in the electronic medical record, paired ...
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for ...
Sparsentan cut proteinuria about 70% and kept kidney function stable over 2 years in newly diagnosed IgA nephropathy in the SPARTAN study.
In 2024, Medicare Advantage insurers denied 7.7% of nearly 53 million prior authorization requests, and 80.7% of the 11.5% of denials appealed were overturned. Speakers at ASN Kidney Week urge ...
Weekly initiation of oral semaglutide among US adults eligible for obesity medications rose from nearly 0 to a peak of 4.56 ...
Infectious diseases (ID) and HIV clinicians can shape federal and state policy by pairing patient stories with sustained, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results